$ 249.87See all
Kartalaks intensive 1 month course 180 capsules
Kartalaks is a peptide complex containing amino acids that contribute to the normalization of cartilage tissue and musculoskeletal system.
Diseases of the musculoskeletal system caused by disorders of the connective tissue and cartilage structures, are widespread among patients like the elderly and the young. The urgency of solving the problem of effective care for patients with this pathology is very high, as it often leads to a significant limitation of working capacity, as well as to disability. To correct and prevent connective tissue disorders, occurring in various diseases has been developed bioregulator cartilage - Kartalaks.
In a clinical study of the effectiveness of installed Kartalaks in comprehensive prevention and treatment of patients suffering from osteochondrosis of the spine, osteoarthritis, osteoporosis, after injuries and fractures, as well as in the prevention of sclerotic and degenerative processes in the spine and joints in people with middle and old age.
The drug is combined with any means used for the treatment of this group of diseases.
While taking Kartalaks patients noted a significant smoothing of pathological symptoms, including pain, usually characterized by considerable resistance to conventional therapy.
Kartalaks: clinical trials
In a clinical study of the efficacy of KARTALAKSA included 63 patients with a diagnosis of "Ostsoartroz knee" (18 people, including 11 men, 7 women), "osteochondrosis" (28 people, including 12 men, 16 women), "Osteoporosis "(17 women) aged 45 to 78 years, that the main group.
Patients with osteoarthritis of the knee complained of pain and limited flexion and extension in the joints while walking. In older adults were hallmarks of deformation joints, atrophy of the thigh muscles and weakening of the ligamentous apparatus of joints.
Patients with spinal osteochondrosis often noted the appearance of pain in the lower back radiating to the campaign of the sciatic nerve, however, increases with a change in body position, walking, physical exercise, as well as pain in the thoracic spine. Patients with osteoporosis complained of frequent fractures arising in minor injury or even for no apparent reason. In patients with primary and Control group The duration of the disease ranged from 5 to 20 years and observed a progressive dynamics of the pathological process.
All the patients had previously received long-term analgesics and anti-inflammatory drugs, the use of which caused a short-term therapeutic effect, requiring increasing doses for a course of treatment and duration of their reception.
Patients of the control group treated with conventional means. Patients of the main group, in addition to conventional means of appointed KARTALAKS 1-2 capsules 2-3 times daily with meals for 20 to 30 days.
To assess the effectiveness of KARTALAKS analyzed the dynamics of patients' complaints, as well as objective parameters: clinical blood and urine tests, biochemical blood tests, X-rays.
It should be noted that the radiographic signs of degenerative diseases of joints and spine are not only objective diagnostic criteria for pathological stage of the process, but also have a greater prognostic value when carried out by drug therapy.
It was found that the use of KARTALAKS in patients with osteoarthritis of the knee helped to reduce pain and increase joint mobility in 72.6% of cases. The most painful symptoms completely disappeared at radiographically defined the initial stages of the disease: narrowing of the joint space between the patella and the femur, lateral patellar osteophytes and femoral condyle. The essential dynamics of radiological symptoms were observed during this period. The patients in the advanced stage of osteoarthritis there was a similar, but less pronounced dynamics of subjective indicators. As this stage of the disease has been diagnosed in older adults, that these subjective sensations described as very favorable. In patients with osteochondrosis of the lumbar spine KARTALAKS use of complex therapy helped to reduce pain in 65.3% of cases. Such dynamics is most common in middle-aged persons. Persons older age groups KARTALAKS application for 20-30 days smoothed progressive age-pain symptoms that occurs when the load on the spine and lower limbs, and helped to increase the mobility of the spine. In patients with osteoporosis after prolonged use of the drug (at least 3 courses per year - for 30 days each with an interval of 4 months) was observed stabilization of metabolic processes in the bone tissue, confirmed by densitometric studies: reduced number of characteristic fractures, greatly accelerates the process of restoring the function of the musculoskeletal system and decreased time spent in the hospital. All patients had a significant smoothing of the main symptoms of occurrence of these diseases is characterized by considerable conservatism.
Kartalaks well tolerated, with no side effects were detected, complications, contraindications and drug dependence.
Bioregulator Kartalaks restores the cartilage and their functions
Bioregulator Kartalaks for restoring cartilage and bone tissue, is used in the prevention and treatment of diseases of the spine and joints of the body, from the smallest to largest.
Have effects bioregulator Kartalaks
The joints bear the weight of the entire body. Their normal function depends on proper nutrition, the lifestyle and other factors, including the operation of some of the internal organs.
Bioregulator Kartalaks - a peptide complex, amino acids which normalize the condition of cartilage, bone and connective tissue. Thus, Kartalaks creates all conditions for the restoration of normal functioning of joints and to restore their mobility.
Principles of bioregulator Kartalaks
Bioregulator Kartalaks - a drug to restore the state and joint mobility. It normalizes the process of regeneration of cartilage and bone tissue, provides their nutrition and hydration. The peptide bioregulator Kartalaks used for prevention and treatment of all diseases of the musculoskeletal system. The principles of its operation are the properties, origin and destination of the peptides.
Clinical trials have shown that Kartalaks most effective when integrated use with other medications for the joints and cartilage. It is used in the treatment of this bioregulator any degenerative changes in the tissues of the joints.
Peptides - are short chains of amino acids that form the basis of proteins and are the building blocks for them. Having finished its function in the body, proteins disintegrate into its component parts, peptides which are in turn connected to the chain DNA and start the process of synthesis of new proteins.
Bioregulator peptide Kartalaks consists of amino acids that make up peptides and which are necessary for functional recovery of cartilage and bone cells. Peptides and amino acids and reduced protein synthesis, impaired protein chain. Due to this, normal operation is restored joints. Application bioregulator Kartalaks appropriate to apply periodically to prevent a variety of diseases of the musculoskeletal system.
Bioregulator Kartalaks used at the outset of the disease or at the initial stage of treatment. It has a strong therapeutic effect for a short period, including the resources of the organism. Turning bioregulator Kartalaks in the complex therapy, or use it as a means of prevention of diseases of the joints, provides a faster and more lasting results. So, it is not necessary to use all the time, but rather 2-3 courses per year. Application bioregulator Kartalaks shown in the following testimony.
The results of the application of the bioregulator Kartalaks
Bioregulator peptide Kartalaks - this is a good way to maintain all elements of the musculoskeletal system. It will be useful to athletes and people engaged in heavy physical labor, especially the elderly.
Adults take 1-2 capsules 1-2 times a day with meals. Duration of 10-30 days. It is advisable to repeat the course in 4-6 months.
Important notice - the outer box design may vary before prior notice!